All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 160 of 206 pages ‹ First < 158 159 160 161 162 > Last ›
HSL2215
Mantz B.
Benefit Plan Accuses Bristol-Myers Of Fraud, Racketeering
Dow Jones Newswires 2001 Nov 19
HSL2216
Pinker S.
Medicine's intellectual property rights attacked in Osler lecture
eCMAJ 2001 Nov 19
www.cmaj.ca/cgi/content/full/166/2/230
HSL2217
Lieberman T.
Drug Discounts Offered to Foster Brand Loyalty
Los Angeles Times 2001 Nov 19
http://articles.latimes.com/2001/nov/19/health/he-5905
HSL2213
Seniors Go North For Cheaper Medication
Yahoo News 2001 Nov 16
HSL2210
McNeil D.
Tuberculosis Group Tries to Spur Research for New Antibiotics
New York Times 2001 Nov 15
http://www.nytimes.com/2001/11/15/international/15DRUG.html?pagewanted=1
HSL2211
Richwine L.
Pediatric Drug-Test Incentives Clear House
Reuters 2001 Nov 15
HSL2212
Davenport J.
Brand names carry price: Quebecers paid $18.7 million too much for drugs - generic manufacturers
Montreal Gazette 2001 Nov 15
HSL2209
Green Light to Put Public Health First at WTO Ministerial Conference in Doha
2001 Nov 14
HSL2208
Boseley S.
Tobacco giant buys rights to lung cancer drugs
The Age 2001 Nov 13
http://www.guardian.co.uk/society/2001/nov/12/cancercare
HSL17997
Postmarketing drug surveillance: what it would take to make it work
CMAJ 2001 Nov 13;165:(10):1293-1293
http://www.ncbi.nlm.nih.gov/pubmed/11760966
HSL2207
Agovino T.
Bristol-Myers Aims to Secure Monopoly
AP Business Writer 2001 Nov 12
HSL2206
Spurgeon D.
Report clears researcher who broke drug company agreement
BMJ 2001 Nov 10
HSL2205
Cassels A.
The new drug pushers
Montreal Gazette 2001 Nov 9
HSL2204
Lerner S.
The Bayer Boondoggle
Village Voice 2001 Nov 7
http://www.villagevoice.com/2001-11-06/news/the-bayer-boondoggle/1
HSL137
Byron E.
The Web @ Work / Astra Zeneca: A Weekly Case Study
The Wall Street Journal 2001 Nov 5
HSL2203
Wayne L, Petersen M.
A Muscular Lobby Tries to Shape Nation's Bioterror Plan
New York Times 2001 Nov 4
http://www.nytimes.com/2001/11/04/business/04PHAR.html?pagewanted=1
HSL2513
Silverstein F, Simon L, Faich G.
Reporting of 6-month vs 12-month data in a clinical trial of celecoxib [3rd of 3 letters]
JAMA 2001 Nov 01;286:(19):2399-2400
http://web.archive.org/web/20021019090659/http://jama.ama-assn.org/issues/v286n19/ffull/jlt1121-1.html
HSL7818
Chisholm MA, Garrett CJ.
Increasing transplant patients' access to medications: Medicare and beyond.
Am J Health Syst Pharm 2001 Nov 1;58:(21):2081-4
http://www.ajhp.org/cgi/reprint/58/21/2081
HSL2261
Meek C .
Direct-to-consumer advertising of prescription medicines: A review of international policy and evidence
Royal Pharmaceutical Society of Great Britain 2001 Nov
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL2264
Brodie M.
Understanding the effects of direct-to-consumer prescription drug advertising
: Henry J. Kaiser Family Foundation 2001 Nov
HSL2553
Meek C.
2001 Nov;
http://www.rpsgb.org.uk/pdfs/dtcarep.pdf
HSL7814
Sullivan DL.
Evaluating information in consumer advertisements of prescription drugs.
Ann Pharmacother 2001 Nov;35:(11):1494
http://www.theannals.com/cgi/reprint/35/11/1494-a
HSL16800
Rosack J
Controversy Erupts Over Ads for ADHD Drugs
Psychiatric News 2001 11 02;36:(21):20
http://pn.psychiatryonline.org/cgi/content/full/36/21/20
HSL17995
Carney SL, Nair KR, Sales MA, Walsh J.
Pharmaceutical industry-sponsored meetings: good value or just a free meal?
Intern Med J 2001 Nov;31:(8):488-91
http://www3.interscience.wiley.com/journal/120715721/abstract?CRETRY=1&SRETRY=0
HSL17996
Komesaroff P.
Doctors' interactions with the pharmaceutical industry: science or commerce?
Intern Med J 2001 Nov;31:(8):446-7
http://www3.interscience.wiley.com/journal/120715732/abstract
HSL17998
Hoffman JR
Annals supplement on the American Heart Association proceedings
Ann Emerg Med 2001 Nov;38:(5):605
http://www.ncbi.nlm.nih.gov/pubmed/11679880
HSL2032
Sackett DL.
Why randomized controlled trials fail but needn't: 2 Failure to employ physiological statistics, or the only formula a clinician-trialist is ever likely to need (or understand!).
CMAJ 2001 Oct 30;165:(9):1226-37
http://www.cmaj.ca/cgi/content/full/165/9/1226
HSL17374
Thompson J, Baird P, Downie J
Report of the Committee of Inquiry on the Case Involving Dr Nancy Oliveri, the Hospital for Sick Children, the University of Toronto, and Apotex Inc
2001 Oct 26
www.law.ualberta.ca/centres/hli/userfiles/10_2moelorifrm.pdf
HSL2146
McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS.
Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior.
JAMA 2001 Oct 24-31;286:(16):1994-9
http://jama.ama-assn.org/cgi/content/full/286/16/1994
HSL16742
Wolfe S, Lurie P.
On the Anthrax Front: Fear and Vigilance
The New York Times 2001 Oct 24
HSL2198
Watson R.
Consumer groups fight plans for "direct to patient" drug advertisements
BMJ 2001 Oct 20
HSL18000
Ram FS, Wright J, Brocklebank D, White JE.
Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta (2 )agonists bronchodilators in asthma.
BMJ 2001 Oct 20;323:(7318):901-5
http://www.bmj.com/cgi/content/full/323/7318/901?view=long&pmid=11668134
HSL5309
Attaran A, Gillespie-White L.
Do patents for antiretroviral drugs constrain access to AIDS treatment in Africa?
JAMA 2001 Oct 17;286:(15):1886-92
http://jama.ama-assn.org/cgi/content/full/286/15/1886
HSL2197
Sanders's 'Reasonable drug pricing' amendment
BNA Daily Report for Executives 2001 Oct 15
HSL2195
Norton A.
Magazine Drug Ads Deemed Too Vague
Reuters Health 2001 Oct 5
HSL2196
News of Prescrire's Reps Monitoring Network: Pretences and off-label claims
Prescrire 2001 Oct 01
http://www.ncbi.nlm.nih.gov/pubmed/11824429
HSL2374
Telles Filho PC, Galdeano LE, Miasso AI, Caliri MH, Mendes IA.
[Drug administration and information dissemination via online]
Rev Bras Enferm 2001 Oct-Dec 01;54:(4):539-47
HSL4816
Gupta AS.
Research on hire.
Issues Med Ethics 2001 Oct-Dec;9:(4):111-3
HSL1849
Eliasson G, Hakansson J.
[Keep medical education independent! It should not be a scene of drug industry marketing]
Lakartidningen. 2001 Sep 26;98:(39):4168-9
HSL4577
Elliott C.
Pharma buys a conscience.
Am Prospect 2001 Sep-Oct 24;12:(17):16-20
HSL5565
FDA
NDA 21-042 Vioxx (rofecoxib) tablets MACMIS ID # 9456 WARNING LETTER
: FDA 2001 Sep 21
HSL2193
Silversides A.
Ottawa assailed for reinterpreting ad law
The Globe and Mail 2001 Sep 18
HSL2194
Silversides A.
Looser ad rules a headache for drug plans
The Globe and Mail 2001 Sep 18
HSL6975
Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS; International Committee of Medical Journal Editors.
Sponsorship, authorship and accountability.
CMAJ 2001 Sep 18;165:(6):786-8
HSL2160
Davidoff F, DeAngelis CD, Drazen JM, Hoey J, Hojgaard L, Horton R, Kotzin S, Nicholls MG, Nylenna M, Overbeke AJ, Sox HC, Van Der Weyden MB, Wilkes MS.
Sponsorship, authorship, and accountability.
Lancet 2001 Sep 15;358:(9285):854-6
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060354
HSL2191
Dyer O.
University accused of violating academic freedom to safeguard funding from drug companies
BMJ 2001 Sep 15
HSL13371
Eliasson M, Bergqvist D.
[Research results should be freely accessible!-- Case reports demonstrate obstacles to contact with drug industry].
Lakartidningen 2001 Sep 12;98:(37):3913-6
http://www.ncbi.nlm.nih.gov/pubmed/11586830
HSL17372
Major LE
Scientists' independence in drug trials questioned: Medical journal editors want more information about the role of pharmaceutical companies in drug trials.
The Guardian 2001 Sep 10
http://www.guardian.co.uk/education/2001/sep/10/research.highereducation
HSL19525
An Unhealthy Influence on Doctors
The New York Times 2001 Sep 10
http://www.nytimes.com/2001/09/10/opinion/an-unhealthy-influence-on-doctors.html
HSL2266
McCarthy M.
Drug firm support of American Medical Association ethics effort draws fire.
Lancet 2001 Sep 8;358:(9284):821
http://linkinghub.elsevier.com/retrieve/pii/S0140673601060214
HSL2190
Sigworth SK, Nettleman MD, Cohen GM.
Pharmaceutical Branding of Resident Physicians
JAMA 2001 09 05286:(9):1024-5
http://jama.ama-assn.org/cgi/content/full/286/9/1024-a
HSL2334
Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS.
Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits.
Ann Clin Psychiatry 2001 Sep;13:(3):159-62
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=11791954&query_hl=53
HSL7409
Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS
Graphics in Pharmaceutical Advertisements: Are They Truthful, Are They Adequately Detailed?
Los Angeles: UCLA School of Medicine 2001 Sep
http://www.ama-assn.org/public/peer/prc_program2001.htm#truthful
HSL7767
Antonopoulos J.
Crossing the border: seniors turn to Canada and Mexico to fight high prescription costs
Acta Poloniae Pharmaceutica Drug Research 2001 Sep-Oct;4:4-7
HSL7811
Scheindlin S.
Acacia-remarkable excipient: past, present, and future of gum arabic
Journal of the American Pharmaceutical Association 2001 Sep-Oct;41:669-671
HSL18001
Reidenberg MM.
An open invitation for an explanation about how drug prices are set.
Clin Pharmacol Ther 2001 Sep;70:(3):205-7
http://www.nature.com/clpt/journal/v70/n3/abs/clpt200183a.html
HSL20380
Rakow T
Differences in belief about likely outcomes account for differences in doctors' treatment preferences: but what accounts for the differences in belief?
Qual Health Care. 2001 Sep;10:i44–i49.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1765736/
HSL2189
Okie S.
AMA Blasted for Letting Drug Firms Pay for Ethics Campaign
Washington Post 2001 Aug 30
HSL2186
AMA Discourages Drug Co. Gifts
New York Times 2001 Aug 29
HSL2187
Guyatt G.
Don't allow drug firms to intimidate
Straightgoods 2001 Aug 29
HSL2188
Sheddan A.
Big tick for tighter DTC advertising rules
New Zealand Doctor 2001 Aug 29
HSL16799
Thomas K
Back to school for ADHD drugs
USA Today 2001 Aug 28
http://www.usatoday.com/life/2001-08-28-adhd.htm
HSL2185
Glaxo Is Sued Over Antidepressant
The New York Times 2001 Aug 26
http://www.nytimes.com/2001/08/27/business/glaxo-is-sued-over-antidepressant.html?pagewanted=1
HSL2267
Vallance P.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358:(9282):664
http://linkinghub.elsevier.com/retrieve/pii/S0140673601057919
HSL2294
Reidenberg MM.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358:(9282):664
http://linkinghub.elsevier.com/retrieve/pii/S0140673601057890
HSL2295
Conti Nibali S, Siracusano MF.
Releasing the grip of big pharma.
Lancet 2001 Aug 25;358:(9282):664
HSL2510
Vallance P.
Releasing the grip of big pharma (3rd of 3 letters)
Lancet 2001 Aug 25;358:664
HSL2539
Reidenberg , M .
Releasing the grip of big pharma (1st of 3 letters)
Lancet 2001 Aug 25;358:664
HSL2545
Nibali S.
Releasing the grip of big pharma (2nd of 3 letters)
Lancet 2001 Aug 25;358:664
HSL2183
Burton TM, Harris G.
Study Raises Specter of Cardiac Risk For Users of Popular Arthritis Drugs
The Wall Street Journal 2001 Aug 22
http://online.wsj.com/article/SB99842672681764284.html?mod=googlewsj
HSL2184
Gold R.
States Battling High Drug Costs Appeal to Doctors to Help Fight
The Wall Street Journal 2001 Aug 22
HSL2296
Silversides A.
Direct-to-consumer prescription drug ads getting bolder.
CMAJ 2001 Aug 21;165:(4):462
http://www.cmaj.ca/cgi/content/full/165/4/462
HSL2182
Winslow R, Martinez B.
Pharmacy-Benefit Managers Launch Aggressive Bids to Lower Drug Costs
The Wall Street Journal 2001 Aug 20
HSL41
Jones MI, Greenfield SM, Bradley CP.
Prescribing new drugs: qualitative study of influences on consultants and general practitioners
BMJ 2001;323:378-384
http://bmj.bmjjournals.com/cgi/content/full/323/7309/378
HSL2181
Pearl D.
Drug Firms' Incentives Fuel Abuse by Pharmacists in India
The Wall Street Journal 2001 Aug 16
http://online.wsj.com/article/SB997910373349012375.html?mod=googlewsj
HSL2180
Picard A.
Policy critic likes Rock's prescription
Globe and Mail 2001 Aug 15
HSL20086
King A
Direct-to-consumer advertising rules will become stricter
New Zealand Government 2001 Aug 14
http://www.scoop.co.nz/stories/PA0108/S00284.htm
HSL19789
Washburn J
Undue Influence: How the Drug Industry's Power Goes Unchecked and Why the Problem is Likely to Get Worse
The American Prospect 2001 Aug 13
http://newamerica.net/node/6124
HSL2179
Milloy S.
Medical Journals Hooked on Drug Money
Fox News 2001 Aug 12
www.foxnews.com/story/0,2933,31761,00.html
HSL2178
Kennedy M.
Rock may limit drugs covered by medicare
Ottawa Citizen 2001 Aug 11
HSL2177
States Seek New Methods To Lower Prescription Drug Costs
The Wall Street Journal 2001 Aug 8
HSL2171
Greene J.
Rules governing drug firm CME sponsorship under review
amednews.com American Medical Association 2001 Aug 6
www.ama-assn.org/sci-pubs/amnews/pick_01/prsb0806.htm
HSL2175
Blair J.
Healthy Skepticism and the Marketing of AIDS
New York Times 2001 Aug 5
http://www.nytimes.com/2001/08/05/weekinreview/ideas-trends-healthy-skepticism-and-the-marketing-of-aids.html?pagewanted=1
HSL2176
Coulthart R.
The doctors' gravy train
Channel 9 TV Australia 2001 Aug 5
HSL2174
Adams C.
Glaxo Gets FDA Warning Letter On Improper Avandia Marketing
The Wall Street Journal 2001 Aug 2
http://online.wsj.com/article/SB996704760327413423.html?mod=googlewsj#printMode
HSL2173
Nexium® Offers Unique Advantage Over Generic Omeprazole
www.qfever.com 2001 Aug 1
HSL2086
Beagan BL.
Even if I don't know what I'm doing I can make it look like I know what I'm doing: becoming a doctor in the 1990s.
Can Rev Sociol Anthropol 2001 Aug;38:(3):275-92
HSL2299
Morgan , S .
An assessment of of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume V: predicting the welfare and cost consequences of direct-to-consumer prescription advertising
Centre for Health Services and Policy Research 2001 Aug
HSL2301
Mintzes B Barber ML, Kazanjian K, Evans A
An assessment of the health system impact of direct-to-consumer advertising of prescription medicines (DTCA). Volume III: patient information on medicines. Comparative patient/doctor survey in Vancouver and Sacramento
Centre for Health Services & Policy Research 2001 Aug
http://www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf
HSL2547
Morgan S.
2001 Aug;
http://www.chspr.ubc.ca//hpru/pdf/dtca-v5-econ.pdf
HSL2550
Mintzes , B BARER, Bassett K, Kazanjian A, Evans R.
Untitled
2001 Aug;
www.chspr.ubc.ca//hpru/pdf/dtca-v3-compsurvey.pdf
HSL2552
Mintzes B.
2001 Aug;
http://www.chspr.ubc.ca//hpru/pdf/dtca-v2-litreview.pdf
HSL7805
Wechsler J.
Medicare coverage Redux
Pharmaceutical Executive 2001 Aug;21:16, 18
HSL20302
Landon BE, Reschovsky J, Reed M, Blumenthal D.
Personal, organizational, and market level influences on physicians' practice patterns: results of a national survey of primary care physicians.
Med Care 2001 Aug;39:(8):889-905
http://www.ncbi.nlm.nih.gov/pubmed/11468507
HSL2302
Glass N.
European Commission may reform drug advertising legislation.
Lancet 2001 Jul 28;358:(9278):306
http://linkinghub.elsevier.com/retrieve/pii/S0140673601055283
HSL20116
Mintzes B
Doctor, about that medicine I saw advertised...
In Motion Magazine 2001 July 26
http://www.inmotionmagazine.com/hcare/mintzes.html
HSL20115
Piatt B
Dorgan says committee wants to know effect of direct to consumer drug marketing
US Senator Byron L Dorgan, North Dakota 2001 July 24
HSL19526
Rx R&D Myths: The Case Against The Drug Industry’s R&D 'Scare Card'
Public Citizen 2001 July 23
http://www.citizen.org/publications/publicationredirect.cfm?ID=7065
HSL14777
Susman E.
US doctors touchy on topic of pharma gifts
The Medical Post 2001 Jul 17
HSL7827
Court rules that Maine Rx can move forward
American Journal of Health System Pharmacy 2001 Jul 15;58:1286
Page 160 of 206 pages ‹ First < 158 159 160 161 162 > Last ›
